VRS
RCUS icon

Virginia Retirement Systems’s Arcus Biosciences RCUS Stock Holding History

Virginia Retirement Systems’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$626K Sell
26,250
-1,250
-5% -$25.5K ﹤0.01% 706
2025
Q3 		$374K Sell
27,500
-8,700
-24% -$90.5K ﹤0.01% 810
2025
Q2 		$295K Sell
36,200
-7,800
-18% -$66.6K ﹤0.01% 842
2025
Q1 		$345K Buy
+44,000
New +$510K ﹤0.01% 851
2023
Q3 		$449K Sell
25,000
-15,200
-38% -$305K ﹤0.01% 724
2023
Q2 		$816K Sell
40,200
-18,600
-32% -$354K 0.01% 602
2023
Q1 		$1.07M Buy
58,800
+9,200
+19% +$176K 0.01% 529
2022
Q4 		$1.03M Buy
49,600
+9,400
+23% +$259K 0.01% 602
2022
Q3 		$1.05M Buy
+40,200
New +$1.06M 0.01% 563
2021
Q3 		– Sell
-10,400
Closed -$286K – 1065
2021
Q2 		$286K Buy
10,400
+1,100
+12% +$31.4K ﹤0.01% 930
2021
Q1 		$261K Buy
9,300
+100
+1% +$3.48K ﹤0.01% 1026
2020
Q4 		$239K Buy
+9,200
New +$223K ﹤0.01% 1024

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Virginia Retirement Systems's RCUS Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Arcus Biosciences (RCUS) stake by 4.5% in Q4 2025, selling an estimated $25.5K and leaving 26,250 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Virginia Retirement Systems first reported a position in RCUS in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.07M in Q1 2023. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Virginia Retirement Systems held 26,250 shares of Arcus Biosciences worth $626K as of Q4 2025.
  • Virginia Retirement Systems sold 1,250 Arcus Biosciences shares in Q4 2025, an estimated $25.5K.
  • Arcus Biosciences made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #706 holding.
  • Virginia Retirement Systems first reported a position in Arcus Biosciences in Q4 2020 and has held it in 12 quarters since.
  • Virginia Retirement Systems's Arcus Biosciences position peaked at $1.07M in Q1 2023.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.